{"id":"https://openalex.org/W7164241024","doi":null,"title":"Clinical Application of Actinium-225 Radiopharmaceuticals in Targeted Alpha Therapy","display_name":"Clinical Application of Actinium-225 Radiopharmaceuticals in Targeted Alpha Therapy","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W7164241024"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:8b6b8a9a6c4e4548b0aa705ba16c0fcf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8b6b8a9a6c4e4548b0aa705ba16c0fcf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research in Molecular Medicine, Vol 11, Iss 4, Pp 227-234 (2023)","raw_type":"article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/8b6b8a9a6c4e4548b0aa705ba16c0fcf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082472278","display_name":"Solmaz Mojarad-Jabali","orcid":"https://orcid.org/0000-0001-7260-9120","observed_orcids":["https://orcid.org/0000-0001-7260-9120"]},"institutions":[{"id":"https://openalex.org/I88085062","display_name":"Mazandaran University of Medical Sciences","ror":"https://ror.org/02wkcrp04","country_code":"IR","type":"education","lineage":["https://openalex.org/I88085062"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Solmaz Mojarad-Jabali","raw_affiliation_strings":["\n             1Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran    \n\t"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\n             1Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran    \n\t","institution_ids":["https://openalex.org/I88085062"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007055752","display_name":"Sajjad Molavipordanjani","orcid":"https://orcid.org/0000-0001-5143-9695","observed_orcids":["https://orcid.org/0000-0001-5143-9695"]},"institutions":[{"id":"https://openalex.org/I88085062","display_name":"Mazandaran University of Medical Sciences","ror":"https://ror.org/02wkcrp04","country_code":"IR","type":"education","lineage":["https://openalex.org/I88085062"]}],"countries":["IR"],"is_corresponding":false,"raw_author_name":"Sajjad Molavipordanjani","raw_affiliation_strings":["\n             1Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran    \n\t"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\n             1Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran    \n\t","institution_ids":["https://openalex.org/I88085062"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I88085062"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33685816,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10946","display_name":"Radioactivity and Radon Measurements","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/actinium-225","display_name":"actinium-225","score":0.9990000128746033},{"id":"https://openalex.org/keywords/targeted-alpha-therapy","display_name":"targeted alpha therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/radiopharmaceuticals","display_name":"radiopharmaceuticals","score":0.9860000014305115},{"id":"https://openalex.org/keywords/alpha-emitters","display_name":"alpha-emitting radionuclides","score":0.8389999866485596},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.7459999918937683},{"id":"https://openalex.org/keywords/clinical-application","display_name":"clinical application","score":0.5339999794960022},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.5540000200271606},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6833999752998352},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6362000107765198},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.4607999920845032},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42320001125335693},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.390500009059906},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.38609999418258667},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.36800000071525574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36550000309944153},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3625999987125397},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.361299991607666},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.34880000352859497},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.34529998898506165},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.33980000019073486},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.3370000123977661},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.31049999594688416},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.2879999876022339},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27300000190734863},{"id":"https://openalex.org/C136197465","wikidata":"https://www.wikidata.org/wiki/Q1729295","display_name":"Variety (cybernetics)","level":2,"score":0.2694999873638153},{"id":"https://openalex.org/C2983812674","wikidata":"https://www.wikidata.org/wiki/Q134808","display_name":"Delivery system","level":2,"score":0.26829999685287476}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:8b6b8a9a6c4e4548b0aa705ba16c0fcf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8b6b8a9a6c4e4548b0aa705ba16c0fcf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research in Molecular Medicine, Vol 11, Iss 4, Pp 227-234 (2023)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:8b6b8a9a6c4e4548b0aa705ba16c0fcf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8b6b8a9a6c4e4548b0aa705ba16c0fcf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research in Molecular Medicine, Vol 11, Iss 4, Pp 227-234 (2023)","raw_type":"article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7221326806","https://openalex.org/W7078245190","https://openalex.org/W4386796221","https://openalex.org/W4404313264","https://openalex.org/W4403477476","https://openalex.org/W4414311906","https://openalex.org/W2034149747","https://openalex.org/W4389264105","https://openalex.org/W3082474830","https://openalex.org/W4380683109"],"abstract_inverted_index":{"Among":[0],"the":[1,21,25,42,55,61],"vast":[2],"variety":[3],"of":[4,9,23,27,44,64],"radionuclides":[5],"available,":[6],"a":[7],"handful":[8],"them":[10],"possess":[11],"proper":[12],"features":[13],"for":[14,39],"targeted":[15],"alpha":[16],"therapy":[17],"(TAT).":[18],"TAT":[19,40],"holds":[20],"promise":[22],"exceeding":[24],"effectiveness":[26],"conventional":[28],"radiotherapy":[29],"methods.":[30],"Actinium-225":[31],"is":[32],"considered":[33],"to":[34,47],"be":[35],"an":[36],"outstanding":[37],"isotope":[38],"in":[41],"management":[43],"cancer":[45],"due":[46],"its":[48],"half-life,":[49],"which":[50],"enables":[51],"sustained":[52],"delivery":[53],"at":[54],"tumor":[56],"site.":[57],"This":[58],"review":[59],"covers":[60],"clinical":[62],"applications":[63],"actinium-225":[65],"radiopharmaceuticals.":[66]},"counts_by_year":[],"updated_date":"2026-06-11T06:27:03.387118","created_date":"2026-06-11T00:00:00"}